Removal of minute virus of mice-mock virus particles by nanofiltration of culture growth medium supplemented with 10% human platelet lysate

• Declaration of Competing Interest NW and MT are employees of Asahi Kasei Medical. TB is the treasurer of the Working Party on Cellular Therapies of the International Society of Blood Transfusion. Funding This study was partially funded by Asahi Kasei Medical, Tokyo, Japan, through a research agreement with Taipei Medical University. The sponsor played no role in data collection, analysis or interpretation; manuscript writing; or the decision to submit the article for publication. Author Contributions Conception and design of the study: TB, NK, MT, FK. Acquisition of data: LB, ON, LD, YWW. Analysis and interpretation of data: LB, ON, LD, YWW, NK, MT, TB. Drafting or revising the manuscript: LB, TB, FK, NK, MT. All authors have approved the final article. Acknowledgments The authors thank the Uppsala University blood bank, Uppsala, Sweden, and Taipei Blood Center, Guandu, Taiwan, for supplying platelet concentrates.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Hematologi (hsv//swe)

MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Hematology (hsv//eng)

Keyword

HPL

human platelet lysate

log reduction value

nanofiltration

viral clearance

Publication and Content Type

ref (subject category)

art (subject category)